Luckys Pharma Lab Private Limited

Glimiford, marketed by Luckys Pharma Lab Pvt. Ltd., is a clinically trusted oral anti-diabetic formulation that combines Glimepiride and Metformin Hydrochloride to provide effective glycemic control in patients with Type 2 Diabetes Mellitus. Glimepiride, a sulfonylurea, works by stimulating insulin secretion from the pancreas, while Metformin, a biguanide, reduces hepatic glucose production and enhances peripheral insulin sensitivity. This dual-action therapy addresses both insulin deficiency and resistance, helping manage both fasting and postprandial blood glucose levels. Glimiford is well-tolerated, does not cause significant weight gain, and offers a convenient and cost-effective solution for long-term diabetes management. It is available in multiple strengths to suit individual patient needs, and is backed by the trusted quality and commitment of Luckys Pharma Lab Pvt. Ltd.

Divalproex Sodium is a compound that dissociates to the valproate ion in the gastrointestinal tract. It is used to treat various types of seizure disorders, prevent migraine headaches, and manage bipolar disorder. It works by increasing the amount of a certain natural substance in the brain.

Divalproex Sodium increases the concentration of gamma-aminobutyric acid (GABA) in the brain, an inhibitory neurotransmitter, which helps to stabilize neuronal activity and reduce seizures and mood swings.

Divoteas 500 Tablet (Divalproex Sodium 500 mg) is indicated for:

• Epilepsy (various types of seizures)
• Bipolar disorder (for the treatment of manic episodes)
• Migraine prophylaxis (prevention of migraine headaches)

• Dosage: The dosage of Divalproex Sodium varies based on the condition being treated. For epilepsy, initial doses are typically around 10-15 mg/kg/day, increasing gradually. For bipolar disorder, initial doses can start at 750 mg/day, while for migraine prevention, the initial dose might be around 250 mg twice daily.
• Administration: Tablets should be taken orally, swallowed whole, and can be taken with or without food. Do not crush or chew the tablets.

Flownxyn P Nasal Drops contain Xylometazoline Hydrochloride, a nasal decongestant used to relieve nasal congestion associated with colds, allergies, sinusitis, and other upper respiratory tract infections. Xylometazoline works by constricting the blood vessels in the nasal passages, leading to decreased swelling and congestion.

Xylometazoline is a sympathomimetic agent that primarily acts on alpha-adrenergic receptors in the nasal mucosa. By stimulating these receptors, it causes vasoconstriction, which reduces blood flow to the nasal passages and decreases swelling, allowing for easier breathing.

Flownxyn P Nasal Drops are indicated for:

• Relief of nasal congestion due to common colds
• Relief of nasal congestion associated with allergic rhinitis
• Relief of nasal congestion caused by sinusitis
• Relief of nasal congestion due to other upper respiratory tract infections

Vilflo F is an inhalation rotacap formulation combining fluticasone furoate and vilanterol, designed to effectively manage asthma and chronic obstructive pulmonary disease (COPD). Fluticasone furoate is a potent corticosteroid that reduces inflammation in the airways, thereby preventing asthma attacks and COPD exacerbations. It works by inhibiting the release of inflammatory mediators and reducing the swelling and mucus production in the lungs. Vilanterol, on the other hand, is a long-acting beta-agonist (LABA) that acts by relaxing the muscles in the airways, allowing them to open up and improving airflow into the lungs.

Administered via a dry powder inhaler (DPI), Vilflo F delivers the medication directly into the lungs with each inhalation. This method ensures efficient absorption and distribution of both active ingredients, providing both immediate and long-lasting relief from respiratory symptoms. Vilflo F is typically used once daily as maintenance therapy to control symptoms and prevent exacerbations in patients with asthma or COPD.

The combination of fluticasone furoate and vilanterol in Vilflo F offers complementary actions, addressing both the underlying inflammation and bronchoconstriction associated with chronic respiratory conditions. By providing effective bronchodilation and anti-inflammatory effects, Vilflo F helps patients achieve better control of their respiratory symptoms, including wheezing, shortness of breath, and coughing.

• Cardiac Diabetic
• Gastrointestinal
• Antibiotics
• Pediatrics
• Neurological
• Gynaecology
• Antacids
• Antihistamines
• Orthopedic

• Cardiac Diabetic
• Gastrointestinal
• Antibiotics
• Pediatrics
• Neurological
• Gynaecology
• Antacids
• Antihistamines
• Orthopedic

• Cardiac Diabetic
• Gastrointestinal
• Antibiotics
• Pediatrics
• Neurological
• Gynaecology
• Antacids
• Antihistamines
• Orthopedic

• Cardiac Diabetic
• Gastrointestinal
• Antibiotics
• Pediatrics
• Neurological
• Gynaecology
• Antacids
• Antihistamines
• Orthopedic

• Cardiac Diabetic
• Gastrointestinal
• Antibiotics
• Pediatrics
• Neurological
• Gynaecology
• Antacids
• Antihistamines
• Orthopedic

• Cardiac Diabetic
• Gastrointestinal
• Antibiotics
• Pediatrics
• Neurological
• Gynaecology
• Antacids
• Antihistamines
• Orthopedic

• Cardiac Diabetic
• Gastrointestinal
• Antibiotics
• Pediatrics
• Neurological
• Gynaecology
• Antacids
• Antihistamines
• Orthopedic

Lazo 40/80 is a potent medication containing Pantoprazole in gastro-resistant tablet form, available in 40 mg and 80 mg dosages. Pantoprazole is a proton pump inhibitor (PPI) that works by reducing the amount of acid produced in the stomach, providing effective relief from acid-related conditions such as gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome. The gastro-resistant formulation ensures that the active ingredient is released in the intestines rather than the stomach, maximizing its efficacy while minimizing potential irritation to the stomach lining.

Lazo 40/80 is particularly beneficial for patients who experience persistent heartburn, acid reflux, or other symptoms associated with excess stomach acid. By controlling acid production, it not only provides symptomatic relief but also promotes healing of the esophagus and stomach lining, preventing further complications such as ulcers and esophageal damage.

Lazo 40/80 is a reliable and effective treatment option for those requiring long-term management of acid-related disorders, ensuring consistent relief and improved digestive health.

Medine 4/8 is a potent corticosteroid medication containing Methylprednisolone, available in 4 mg and 8 mg tablet formulations, designed to manage a broad spectrum of inflammatory and autoimmune conditions. Methylprednisolone is renowned for its powerful anti-inflammatory and immunosuppressive effects, making it a critical treatment option for conditions such as rheumatoid arthritis, lupus, severe allergies, asthma, and certain skin disorders. By reducing inflammation and modulating the immune system, Medine 4/8 helps alleviate symptoms like pain, swelling, redness, and allergic reactions, providing significant relief to patients suffering from chronic and acute conditions.

Medine 4/8 is also widely used in managing flare-ups of chronic diseases, ensuring that patients experience reduced severity and duration of symptoms. Additionally, it plays a crucial role in preventing organ rejection in transplant patients by suppressing the immune response. The flexibility of dosing with Medine 4 and 8 mg tablets allows for personalized treatment plans, ensuring that each patient receives the appropriate dosage to effectively manage their condition.

Lace SP is a combination medication featuring Aceclofenac and Paracetamol, designed to provide potent relief from pain and inflammation. Aceclofenac is a nonsteroidal anti-inflammatory drug (NSAID) that works by inhibiting the synthesis of prostaglandins, chemical messengers in the body responsible for pain, fever, and inflammation. Paracetamol, also known as acetaminophen, complements Aceclofenac by providing additional pain relief and reducing fever.

Lace P is particularly effective in treating conditions such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and other musculoskeletal disorders where pain and inflammation are prominent. The combination of these two active ingredients ensures rapid relief from symptoms, improving mobility and enhancing the quality of life for individuals suffering from chronic pain conditions.

Lace P is an excellent choice for those seeking a balanced and effective solution for pain and inflammation, offering the dual benefits of an NSAID and an analgesic in one convenient tablet.

Divoteas 250/500 is a medication containing Divalproex Sodium, available in 250 mg and 500 mg tablet formulations. Divalproex Sodium is a versatile anticonvulsant and mood-stabilizing drug used primarily in the management of epilepsy, bipolar disorder, and migraine prophylaxis. It works by increasing the levels of gamma-aminobutyric acid (GABA) in the brain, a neurotransmitter that helps to calm excessive nerve activity, thus reducing the frequency and severity of seizures and stabilizing mood swings.

In epilepsy, Divoteas helps control various types of seizures, including generalized tonic-clonic, absence, and partial seizures. For individuals with bipolar disorder, it assists in managing manic episodes and stabilizing mood, preventing extreme mood swings. Additionally, Divoteas is effective in preventing migraines, reducing the frequency of headache episodes and associated symptoms.

The flexibility of dosing with Divoteas 250/500 allows for precise management tailored to the patient’s specific needs and condition severity. This makes Divoteas a reliable option for those seeking effective control of seizure disorders, mood stabilization, and migraine prevention, ultimately enhancing the quality of life and overall well-being.

Levoice A2 contains Acebrophylline 100 mg and Acetylcysteine 600 mg, a combination used primarily in the management of respiratory conditions like chronic obstructive pulmonary disease (COPD) and bronchial asthma.

• Acebrophylline 100 mg: A bronchodilator with mucolytic and anti-inflammatory properties. It helps in relaxing the smooth muscles of the airways, reducing inflammation, and promoting mucus clearance, thus improving breathing.

• Acetylcysteine 600 mg: A mucolytic agent that breaks down thick mucus, making it easier to expel. It helps in reducing the viscosity of secretions, which facilitates better lung function and helps in alleviating symptoms like cough and congestion.